Shravan Chemopharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 29.67%
- Ebitda
- Net Worth -84.07%
- Total Assets 3.61%
About Shravan Chemopharma
Shravan Chemopharma Private Limited (SCPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 March 2019 (Five years and ten months 17 days old ). Its registered office is in Bharuch, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mamta Bhomia and Vinay Bhomia serve as directors at the Company.
Company Details
-
Location
Bharuch, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24110GJ2019PTC107158
-
Company No.
107158
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Mar 2019
-
Date of AGM
21 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Shravan Chemopharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mamta Bhomia
|
Additional Director | 01-Feb-2020 | Current |
|
Vinay Bhomia
|
Additional Director | 01-Feb-2020 | Current |
Financial Performance of Shravan Chemopharma.
Shravan Chemopharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 29.67% increase in profit. The company's net worth observed a substantial decline by a decrease of 84.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shravan Chemopharma?
In 2023, Shravan Chemopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sanjivani Super Speciality Hospitals Private LimitedMamta Bhomia and Vinay Bhomia are mutual person
-
Sanghpura Fasteners LlpMamta Bhomia and Vinay Bhomia are mutual person
-
Shyam Exotica Private Limited
Mamta Bhomia and Vinay Bhomia are mutual person
-
Chj Holdings Private Limited
Mamta Bhomia and Vinay Bhomia are mutual person
-
Therapeia Biosciences Private Limited
Mamta Bhomia and Vinay Bhomia are mutual person
-
Vibgyor Insurance Service Llp
Vinay Bhomia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shravan Chemopharma?
Unlock and access historical data on people associated with Shravan Chemopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shravan Chemopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shravan Chemopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
